VODPF
VODAFONE GROUP PUBLIC LTD CO
$1.55
0.00%
No data for this timeframe.
Vol
SEC Reports5
Recent Activity
May 15, 2026
SEC
Vodafone announced routine board and committee changes: Olaf Koch will join as a non-executive director (subject to AGM
6-K — Impact 2/10
May 12, 2026
SEC
Vodafone reported FY26 preliminary results with revenue up 8.0% to €40.5 billion and organic service revenue growth of 5
6-K — Impact 6/10
May 12, 2026
SEC
Vodafone announced the completion of its irrevocable share buyback programme, purchasing the final 3,685,754 shares at a
6-K — Impact 2/10
Analyst Ratings
5Strong Buy
10Buy
7Hold
5Sell
1Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 2 mixed, 3 neutral. Avg impact: 3.6/10.
NEUTRAL
6-K
2/10
Vodafone announced routine board and committee changes: Olaf Koch will join as a non-executive direc
May 15, 2026
MIXED
6-K
6/10
Vodafone reported FY26 preliminary results with revenue up 8.0% to €40.5 billion and organic service
May 12, 2026
NEUTRAL
6-K
2/10
Vodafone announced the completion of its irrevocable share buyback programme, purchasing the final 3
May 12, 2026
MIXED
6-K
6/10
Vodafone announced a £4.3 billion ($4.9 billion) buyout of CK Hutchison's 49% stake in the VodafoneT
May 5, 2026
NEUTRAL
6-K
2/10
Vodafone Group disclosed its total voting rights as of March 31, 2026, reporting 23,087,114,293 ordi
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 54% buy across 28 analysts — 5 strong buy, 10 buy, 7 hold, 5 sell, 1 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2027-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $43.1B | — | — |
| Next FY 2028-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $44.2B | 2.5% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 5 | 10 | 7 | 5 | 1 | 54% | |
| Apr 1, 2026 | 5 | 10 | 7 | 5 | 1 | 54% | |
| Mar 1, 2026 | 5 | 10 | 7 | 5 | 1 | 54% | |
| Feb 1, 2026 | 5 | 11 | 7 | 4 | 1 | 57% | |
| Jan 1, 2026 | 5 | 9 | 8 | 4 | 1 | 52% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.